abstract |
The present invention relates to a novel compound for activating RORĪ± genes, and to salts thereof. More specifically, the present invention relates to a novel JC1 compound containing CGP52608, which is a thiazolidinedione, as a lead substance, and to pharmaceutically acceptable salts of the compound. Further, the present invention relates to a lipid accumulation inhibitor comprising said novel compound as an active ingredient. The compound of the present invention is expected to be applied to the treatment of metabolic diseases or inflammatory diseases. |